Mindpeak focuses on integrating artificial intelligence in the clinical pathology sector. The company offers AI-powered diagnostic software and AI algorithms that are integrated into histology-based IVDs, including companion diagnostics, to bring precision and speed to clinical pathology. The company primarily sells to the healthcare industry, specifically pathology and university labs. It was founded in 2018 and is based in Hamburg, Germany.

Azra AI focuses on healthcare technology with an emphasis on automating oncology workflows. The company provides artificial intelligence (AI) solutions that identify cancer diagnoses and incidental findings in real-time, automate cancer registry processes, and facilitate tumor board case management. The platform aims to enhance patient care management, offer reporting and analytics, and provide clinical consulting services, serving the healthcare and oncology sectors. Azra AI was formerly known as Invenero Holdings. It was founded in 2022 and is based in Nashville, Tennessee.

Gestalt Diagnostics provides digital pathology solutions within the healthcare industry. The company offers a cloud-based digital pathology enterprise platform, PathFlow®, which is intended to improve the workflow of pathologists and assist in disease diagnosis. Gestalt's services are used by health systems, laboratories, hospitals, and developers focused on digital pathology. It was founded in 2015 and is based in Spokane, Washington.

BioAI focuses on advancing precision medicine through multimodal artificial intelligence within the biopharmaceutical sector. The company offers artificial intelligence (AI) driven services for biomarker discovery, drug target identification, and clinical data sourcing, aiming to enhance drug discovery and clinical development processes. BioAI primarily serves the biopharma industry, leveraging AI to improve disease diagnosis and predict patient responses to therapies. It was founded in 2020 and is based in Manchester, New Hampshire.

Ellogon.AI provides a solution named EIDOS, which utilizes deep learning technology to assist medical experts in selecting suitable patients for immunotherapy by quantifying relevant biomarkers from histopathology images. The company operates within the healthcare sector, specifically targeting medical professionals involved in cancer treatment and research. It was founded in 2019 and is based in Amsterdam, Netherlands.

Ibex specializes in AI-based cancer diagnostics within the healthcare technology sector. The company offers AI-powered diagnostic solutions that assist pathologists in providing accurate and efficient cancer diagnoses. Its solutions are developed using advanced algorithms and digital workflows to detect cancer with clinical-grade accuracy. It was founded in 2016 and is based in Tel Aviv, Israel.